The terms of the contract cannot be less restrictive than Merck/MSDs Travel
policy 9.3, unless dictated by Government regulations. Deviations from this requirement would require Country Managing Director approval (or Band 600 approval for US medical and scientific leader deviations). For travel arrangements that are made outside of our preferred agencies, transfer of value reporting will need to be done locally.